BMS Sotyktu approves for the Treatment of Moderate-to-Severe Plaque Psoriasis
LifeProNow
MARCH 28, 2023
Psoriasis is a widely prevalent, chronic, systemic immune-mediated disease that impacts approximately 14 million people in Europe. The results are particularly meaningful for dermatologists and patients who have been waiting for a more effective and convenient oral therapy to help manage this serious, chronic, immune-mediated disease.”
Let's personalize your content